Literature DB >> 20632972

Trafficking and signaling of G protein-coupled receptors in the nervous system: implications for disease and therapy.

Nigel W Bunnett1, Graeme S Cottrell.   

Abstract

G protein-coupled receptors (GPCRs) are expressed throughout the nervous system where they regulate multiple physiological processes, participate in neurological diseases, and are major targets for therapy. Given that many GPCRs respond to neurotransmitters and hormones that are present in the extracellular fluid and which do not readily cross the plasma membrane, receptor trafficking to and from the plasma membrane is a critically important determinant of cellular responsiveness. Moreover, trafficking of GPCRs throughout the endosomal system can initiate signaling events that are mechanistically and functionally distinct from those operating at the plasma membrane. This review discusses recent advances in the relationship between signaling and trafficking of GPCRs in the nervous system. It summarizes how receptor modifications influence trafficking, discusses mechanisms that regulate GPCR trafficking to and from the plasma membrane, reviews the relationship between trafficking and signaling, and considers the implications of GPCR trafficking to drug development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632972     DOI: 10.2174/187152710793361621

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  7 in total

1.  Opioid receptor function is regulated by post-endocytic peptide processing.

Authors:  Achla Gupta; Ivone Gomes; Jonathan Wardman; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2014-05-20       Impact factor: 5.157

2.  Neuregulin and dopamine modulation of hippocampal gamma oscillations is dependent on dopamine D4 receptors.

Authors:  Richard H Andersson; April Johnston; Paul A Herman; Ursula H Winzer-Serhan; Irina Karavanova; Detlef Vullhorst; André Fisahn; Andres Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-20       Impact factor: 11.205

3.  Mas receptor is translocated to the nucleus upon agonist stimulation in brainstem neurons from spontaneously hypertensive rats but not normotensive rats.

Authors:  Flavia M Cerniello; Mauro G Silva; Oscar A Carretero; Mariela M Gironacci
Journal:  Cardiovasc Res       Date:  2020-10-01       Impact factor: 10.787

Review 4.  Physiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug delivery.

Authors:  Gwen McCaffrey; Thomas P Davis
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

5.  The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story.

Authors:  D Cervia; G Casini
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

6.  Interactions between the FTO and GNB3 genes contribute to varied clinical phenotypes in hypertension.

Authors:  Rahul Kumar; Samantha Kohli; Perwez Alam; Ritankur Barkotoky; Mohit Gupta; Sanjay Tyagi; S K Jain; M A Qadar Pasha
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

7.  CULD is required for rhodopsin and TRPL channel endocytic trafficking and survival of photoreceptor cells.

Authors:  Ying Xu; Tao Wang
Journal:  J Cell Sci       Date:  2015-11-23       Impact factor: 5.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.